Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Glomerulonephritis

• Rescue of Nephrons With ALE.F02 (RENAL-F02)
• An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
• Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
• A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients
• Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis
• Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
• Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency
• Bortezomib for Treating Glomerular Diseases
• Empagliflozin in Patients With Glomerulonephritis
• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
• An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
• Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE)
• A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
• Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
• Efficacy of Corticosteroids in Reducing the Renal Scarring in Acute Pyelonephritis in Children
• Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease
• Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis
• Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis
• Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
• Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy
• Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)
• Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
• Mesenchymal Stromal Cells (MSC´s) in Renal Lupus
• A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
• Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted
• A Proof of Concept Study for a 12 Month Treatment in Patients With C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
• Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
• A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)
• Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
• Effect of Rituximab in Treatment of Membranoproliferative Glomerulonephritis
• A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN
• Daratumumab in Treatment of PGNMID and C3 GN
• Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy
• ACE-inhibitors in Extracapillary Glomerulonephritis
• Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
• Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
• Efficacy and Safety of Losartan in Children With Ig A Nephropathy
• Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis
• A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.
• Eculizumab in Primary MPGN
• Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis
• ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
• Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
• Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
• A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
• Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)
• Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
• Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
• A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy
• Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
• Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis
• A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy
• The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy
• Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
• Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy
• Calcitriol in the Treatment of Immunoglobulin A Nephropathy
• Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis
• Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
• Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
• Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant
• Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor
• A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
• HSP-glomerulonephritis Trial: MP vs CyA
• Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
• A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis
• Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
• ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT
• Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis
• Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis
• Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
• Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis
• Mycophenolate Mofetil in Membranous Nephropathy
• Treatment of Patients With Idiopathic Membranous Nephropathy
• Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
• Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
• Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
• Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy
• Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis
• Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy
• BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis
• Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
• Lamivudine for Chronic Hepatitis B